Efficacy of Chest CT for COVID-19 Pneumonia Diagnosis in France

Guillaume Herpe(Université Rennes 2), Mathieu Léderlin(Université Rennes 2), Mathieu Naudin(Université Rennes 2), Mickaël Ohana(Université Rennes 2), Kathia Chaumoître(Aix-Marseille Université), Jules Grégory(Hôpital Beaujon), Valérie Vilgrain(Hôpital Beaujon), Cornelia Freitag(Université Rennes 2), Constance de Margerie‐Mellon(Université Rennes 2), Violaine Flory(Université Rennes 2), Marie Ludwig(Université Rennes 2), Lydiane Mondot(Centre Hospitalier Universitaire de Nice), Isabelle Fitton(Université Rennes 2), Alexis Jacquier(Université Rennes 2), P. Ardilouze(Université Rennes 2), Isabelle Petit(Université Rennes 2), A. Gervaise(Université Rennes 2), Olivier Bayle(Université Rennes 2), Arielle Crombe(Université Rennes 2), Magloire Mekuko Sokeng(Université Rennes 2), Clement Price Thomas(Université Rennes 2), Geraldine Henry(Université Rennes 2), Virginie Bliah(Université Rennes 2), Thomas Le Tat(Université Rennes 2), Marc-Samir Guillot(Université Rennes 2), Paul Gendrin(Université Rennes 2), Marc Garétier(Université Rennes 2), Estelle Bertolle(Université Rennes 2), Catherine Montagne(Université Rennes 2), Benjamin Langlet(Université Rennes 2), Abdulrazak Kalaaji(Université Rennes 2), Hampar Kayayan(Université Rennes 2), F. Desmots(Université Rennes 2), Benjamin Dhaene(Université Rennes 2), Pierre‐Jean Saulnier(Université Rennes 2), Rémy Guillevin(Université Rennes 2), Jean‐Michel Bartoli(Université Rennes 2), Jean-Paul Bérégi(Université Rennes 2), Jean Pierre Tasu(Université Rennes 2)
Radiology
September 1, 2020
Cited by 81Open Access
Full Text

Abstract

Background The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. Purpose To evaluate the French national experience using chest CT for COVID-19, results of chest CT and reverse transcription polymerase chain reaction (RT-PCR) assays were compared together and with the final discharge diagnosis used as the reference standard. Materials and Methods A structured CT scan survey (NCT04339686) was sent to 26 hospital radiology departments in France between March 2, 2020, and April 24, 2020. These dates correspond to the peak of the national COVID-19 epidemic. Radiology departments were selected to reflect the estimated geographic prevalence heterogeneities of the epidemic. All symptomatic patients suspected of having COVID-19 pneumonia who underwent both initial chest CT and at least one RT-PCR test within 48 hours were included. The final discharge diagnosis, based on multiparametric items, was recorded. Data for each center were prospectively collected and gathered each week. Test efficacy was determined by using the Mann-Whitney test, Student t test, χ2 test, and Pearson correlation coefficient. P < .05 indicated a significant difference. Results Twenty-six of 26 hospital radiology departments responded to the survey, with 7500 patients entered; 2652 did not have RT-PCR test results or had unknown or excess delay between the RT-PCR test and CT. After exclusions, 4824 patients (mean age, 64 years ± 19 [standard deviation], 2669 male) were included. With final diagnosis as the reference, 2564 of the 4824 patients had COVID-19 (53%). Sensitivity, specificity, negative predictive value, and positive predictive value of chest CT in the diagnosis of COVID-19 were 2319 of 2564 (90%; 95% CI: 89, 91), 2056 of 2260 (91%; 95% CI: 91, 92), 2056 of 2300 (89%; 95% CI: 87, 90), and 2319 of 2524 (92%; 95% CI: 91, 93), respectively. There was no significant difference for chest CT efficacy among the 26 geographically separate sites, each with varying amounts of disease prevalence. Conclusion Use of chest CT for the initial diagnosis and triage of patients suspected of having coronavirus disease 2019 was successful. © RSNA, 2021 Online supplemental material is available for this article.


Related Papers

No related papers found

Powered by citation graph analysis